Clinical Trial Update: Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer [NA]

View source ↗

Summary

This document notes that a clinical trial evaluating pirfenidone for radiation-induced fibrosis in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Radiation Fibrosis | NA | Status: COMPLETED